These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 19720731)

  • 1. Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.
    Usui T; Mise M; Hashizume T; Yabuki M; Komuro S
    Drug Metab Dispos; 2009 Dec; 37(12):2383-92. PubMed ID: 19720731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of in vitro combination assays of mitochondrial dysfunction and apoptosis for the estimation of potential risk of idiosyncratic drug induced liver injury.
    Goda K; Takahashi T; Kobayashi A; Shoda T; Kuno H; Sugai S
    J Toxicol Sci; 2016; 41(5):605-15. PubMed ID: 27665770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.
    Obach RS; Kalgutkar AS; Soglia JR; Zhao SX
    Chem Res Toxicol; 2008 Sep; 21(9):1814-22. PubMed ID: 18690722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
    Gómez-Lechón MJ; Tolosa L; Donato MT
    J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeabilized Cryopreserved Human Hepatocytes as an Exogenous Metabolic System in a Novel Metabolism-Dependent Cytotoxicity Assay for the Evaluation of Metabolic Activation and Detoxification of Drugs Associated with Drug-Induced Liver Injuries: Results with Acetaminophen, Amiodarone, Cyclophosphamide, Ketoconazole, Nefazodone, and Troglitazone.
    Wei H; Li AP
    Drug Metab Dispos; 2022 Feb; 50(2):140-149. PubMed ID: 34750194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
    Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
    Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation of hepatotoxic drug (benzbromarone) induced mitochondrial membrane permeability transition.
    Shirakawa M; Sekine S; Tanaka A; Horie T; Ito K
    Toxicol Appl Pharmacol; 2015 Oct; 288(1):12-8. PubMed ID: 26148448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in covalent binding of 5-hydroxydiclofenac to hepatic tissues in rats co-treated with lipopolysaccharide and diclofenac: involvement in the onset of diclofenac-induced idiosyncratic hepatotoxicity.
    Kishida T; Onozato T; Kanazawa T; Tanaka S; Kuroda J
    J Toxicol Sci; 2012; 37(6):1143-56. PubMed ID: 23208430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
    Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
    Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats.
    Yamazaki M; Miyake M; Sato H; Masutomi N; Tsutsui N; Adam KP; Alexander DC; Lawton KA; Milburn MV; Ryals JA; Wulff JE; Guo L
    Toxicol Appl Pharmacol; 2013 Apr; 268(1):79-89. PubMed ID: 23360887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of cytochrome P450-mediated metabolism and involvement of reactive metabolite formations on antiepileptic drug-induced liver injuries.
    Sasaki E; Yokoi T
    J Toxicol Sci; 2018; 43(2):75-87. PubMed ID: 29479037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles.
    Zhang J; Doshi U; Suzuki A; Chang CW; Borlak J; Li AP; Tong W
    Chem Biol Interact; 2016 Aug; 255():3-11. PubMed ID: 26581450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
    Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
    Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.
    Kretz-Rommel A; Boelsterli UA
    Drug Metab Dispos; 1994; 22(6):956-61. PubMed ID: 7895615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human hepatocytes and liver S-9 fraction.
    Bauman JN; Kelly JM; Tripathy S; Zhao SX; Lam WW; Kalgutkar AS; Obach RS
    Chem Res Toxicol; 2009 Feb; 22(2):332-40. PubMed ID: 19161298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microsomal metabolism in bromfenac-induced cytotoxicity.
    Jeon JS; Kim H; Jo S; Sim J; Kim SK
    Chem Biol Interact; 2024 Mar; 391():110903. PubMed ID: 38331335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: comparison with two directly hepatotoxic drugs.
    Lecoeur S; Bonierbale E; Challine D; Gautier JC; Valadon P; Dansette PM; Catinot R; Ballet F; Mansuy D; Beaune PH
    Chem Res Toxicol; 1994; 7(3):434-42. PubMed ID: 8075377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimesulide-induced electrophile stress activates Nrf2 in human hepatocytes and mice but is not sufficient to induce hepatotoxicity in Nrf2-deficient mice.
    Kale VM; Hsiao CJ; Boelsterli UA
    Chem Res Toxicol; 2010 May; 23(5):967-76. PubMed ID: 20405857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.